Catalyst Wire Dossier Catalyst Wire Dossier

Rasilez HCT

aliskiren; hydrochlorothiazide · Noden Pharma DAC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rasilez HCT, covering 2022-05-20 to 2022-05-20. Get the full timeline:

Most recent: EMA Withdrawn: Rasilez HCT (aliskiren;hydrochlorothiazide) — Noden Pharma DAC

See pricing